|
|
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received for publication February 8, 2007.
Revised May 10, 2007.
Accepted for publication May 10, 2007.
The aim of the present study was to investigate whether KV3.4 channel subunits are involved in neuronal death induced by neurotoxic
-amyloid peptides (A
). Particularly, to test this hypothesis, three main questions were addressed: (1) whether the A
peptide can up-regulate both the transcription/translocation and activity of KV3.4 channel subunit, as well as its accessory subunit MIRP2; (2) whether the increase in KV3.4 expression and activity can be mediated by the NF-kB family of transcriptional factors; (3) whether the specific inhibition of KV3.4 channel subunit reverts the A
npeptide-induced neurodegeneration in hippocampal neurons and NGF-differentiated PC-12 cells. We found that A
1-42 treatment induced an increase in KV3.4 and MIRP-2 transcripts and proteins, detected by RT-PCR and by Western blot analysis, in NGF-differentiated PC-12 cells and hippocampal neurons. Patch-clamp experiments performed in whole cell configuration revealed that the A
peptide caused an increase in IA current amplitude carried by KV3.4 channel subunits, as revealed by their specific blockade with BDS-I both in hippocampal neurons and NGF-differentiated PC-12 cells. The inhibition of NF-kB nuclear translocation with the cell-membrane permeable peptide SN-50 prevented the increase in KV3.4 protein and transcript expression. In addition, the SN-50 able to block A
1-42-induced increase in KV3.4 K+ currents and to prevent cell death caused by A
1-42 exposure. Finally, BDS-I toxin produced a similar neuroprotective effect by inhibiting the increase in KV3.4 expression. Collectively, our data indicate that KV3.4 channels could be a novel target for therapeutic strategy of AD.
Key words:
Ion channel regulation, Potassium, NFkappaB, Fluorescence techniques, Immunocytochemistry
This article has been cited by other articles:
![]() |
E. Choi and G. W. Abbott The MiRP2-Kv3.4 Potassium Channel: Muscling In on Alzheimer's Disease Mol. Pharmacol., September 1, 2007; 72(3): 499 - 501. [Abstract] [Full Text] [PDF] |
||||